FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/03/018252 [Registered on: 25/03/2019] Trial Registered Prospectively
Last Modified On: 25/03/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   comparison of Yavani churna and Kampillaka churna in the treatment of worm infestation in age group 3-6 yeras. 
Scientific Title of Study   A standard controlled clinical trial of Yavani churna and Kampillaka churna in the management of Pureeshaja krimi in children 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanket Prakash Khedekar 
Designation  PG Student 
Affiliation  College of ayurved and research centre Akurdi Pune 
Address  PDEAs College of Ayurved and Research centre Akurdi Pune 44

Pune
MAHARASHTRA
411044
India 
Phone  9665006787  
Fax    
Email  sanketkhedekar75@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Madhavi Sanjay Deodas 
Designation  HOD And Guide 
Affiliation  College of ayurved and research centre Akurdi Pune 
Address  PDEAs College of Ayurved and Research centre Akurdi Pune 44

Pune
MAHARASHTRA
411044
India 
Phone  9423010818  
Fax    
Email  drdeodasms@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanket Prakash Khedekar 
Designation  PG Student 
Affiliation  College of ayurved and research centre Akurdi Pune 
Address  PDEAs College of Ayurved and Research centre Akurdi Pune 44

Pune
MAHARASHTRA
411044
India 
Phone  9665006787  
Fax    
Email  sanketkhedekar75@gmail.com  
 
Source of Monetary or Material Support  
PDEAs College of Ayurved And Research centre 3rd floor kaumarbhritya department Akurdi pradhikaran sector no25 Pune 44 
 
Primary Sponsor  
Name  CARC Nigdi Pune  
Address  Nigdi pradhikaran Sec 25 Akurdi Pune 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanket Prakash Khedekar  Ayurved Rugnalaya and Sterling multi speciality Hospital Nigdi  Vitthal Rukhamini road sector 27 Nigdi Pradhikaran pune 411044 Name of OPD- Kaumarbhritya no of OPD-118 on ground floor Pune MAHARASHTRA
Pune
MAHARASHTRA 
9665006787

sanketkhedekar75@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institunationl ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K929||Disease of digestive system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  kampillaka churna  kampillaka churna is prepared by churna kalpana and will be given orally to the children in between 3-6 years of age.the dose is calculated by clarks formula which is 85mg/kg/dayand will be given twice a day before meal which includes follow up on 7th,14,21st,28day. 
Intervention  Yavani churna  Yavani churna is prepared by churna kalpana and will be given orally to the children in between 3-6 years of age.the dose is calculated by clarks formula which is 75mg/kg/dayand will be given twice a day before meal which includes follow up on 7th,14,21st,28day. 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  6.00 Year(s)
Gender  Both 
Details  1.Patient between the age group 3-6 years
2.history of krimipatan
3.Exihibiting symptoms of worm infestation such as
agnimandya,panduta,krushta,rukshata,Gudkandu,Udarshool,Atisara(asthang hridaya 14/56) 
 
ExclusionCriteria 
Details  1.Acute symptoms like acute abdominal pain,severe diarrheoa,severe vomiting,high grade fever.
2.Any congenital gastrointestinal anamolies like intestinal obstruction. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the role of Yavani churna and kampillaka churna in the management of pureeshaja krimi.  28 days with follow up on 7th,14th,21st,28th day 
 
Secondary Outcome  
Outcome  TimePoints 
1.To study the effect of Yavani churna
2.To study the effect of kampillaka churna.
3.To observe the adverse effect of Yavani churna and kampillaka churna ,if any 
28 days. 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   25/03/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NONE YET 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Helminthiasis is the most common peditric complaint world wide.most of world’s population is infected with one or more most common parasites like round worms,hook worms and whipworms.
The complaints towards the infestation of intestinal worms come with greater incidence in pediatric practice.
Helminthiasis is ignored by parents because of less severity of symptoms till the infection becomes severe.
and many anti helminthic drugs have many adverse effects like diarrhoea,nausea,abdominal pain,dizziness,headache,fever,jaundice. 
However yavani churna is deepniya,pachniya which increases apetite also it is kaphavataashamaka and krimighna.and kampillaka also has krimighna property.Hence these drugs are selected in this study
 
Close